Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Histopathology
|
July 1, 1989
DNA flow cytometry of thymomas
S E Davies, J C Macartney, R S Camplejohn, et al.
Clinical and Laboratory Haematology
|
January 1, 1986
Screening tests for Sezary cells in cutaneous T-cell lymphomas
J A Newton, D L Guthrie, N B Westwood, et al.
British Journal of Cancer
|
April 1, 1993
Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells
R S Camplejohn, A Brock, D M Barnes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?
D M Barnes, J Bartkova, R S Camplejohn, et al.
Lancet (London, England)
|
March 19, 1988
Perioperative bromocriptine adjuvant treatment for operable breast cancer
I S Fentiman, K Brame, M A Chaudary, et al.
British Journal of Cancer
|
March 1, 1991
The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer
S M O'Reilly, D M Barnes, R S Camplejohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1990
Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry
S M O'Reilly, R S Camplejohn, D M Barnes, et al.
British Journal of Cancer
|
April 17, 1999
Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations
J M Boyle, M J Greaves, R S Camplejohn, et al.
The Journal of Pathology
|
February 22, 2002
Mitotic counts provide additional prognostic information in grade II mammary carcinoma
J Lynch, R Pattekar, D M Barnes, et al.
British Journal of Cancer
|
January 1, 1996
An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model
H Thomas, A M Hanby, R A Smith, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Histopathology
|
July 1, 1989
DNA flow cytometry of thymomas
S E Davies, J C Macartney, R S Camplejohn, et al.
Clinical and Laboratory Haematology
|
January 1, 1986
Screening tests for Sezary cells in cutaneous T-cell lymphomas
J A Newton, D L Guthrie, N B Westwood, et al.
British Journal of Cancer
|
April 1, 1993
Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells
R S Camplejohn, A Brock, D M Barnes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?
D M Barnes, J Bartkova, R S Camplejohn, et al.
Lancet (London, England)
|
March 19, 1988
Perioperative bromocriptine adjuvant treatment for operable breast cancer
I S Fentiman, K Brame, M A Chaudary, et al.
British Journal of Cancer
|
March 1, 1991
The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer
S M O'Reilly, D M Barnes, R S Camplejohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1990
Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry
S M O'Reilly, R S Camplejohn, D M Barnes, et al.
British Journal of Cancer
|
April 17, 1999
Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations
J M Boyle, M J Greaves, R S Camplejohn, et al.
The Journal of Pathology
|
February 22, 2002
Mitotic counts provide additional prognostic information in grade II mammary carcinoma
J Lynch, R Pattekar, D M Barnes, et al.
British Journal of Cancer
|
January 1, 1996
An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model
H Thomas, A M Hanby, R A Smith, et al.
Page
of 7